Boji Pharmacy: On March 19th, a first-time reduction of 858,500 shares was repurchased.

Boji Pharmaceuticals announced that on March 19, 2026, the company first reduced its repurchased shares by 858,500 shares through centralized bidding trading, accounting for 0.22% of the current total share capital of the company. The total amount of funds obtained from the reduction was 8.5947 million yuan, with an average transaction price of 10.01 yuan per share. The company had previously repurchased a total of 2.667 million shares from February to March 2024. This reduction is in line with the reduction plan and relevant regulations, however, there are uncertainties in the implementation of this reduction plan, and the company will fulfill its disclosure obligations in a timely manner.